Most users implement the stack after establishing tolerance to Retatrutide alone, typically after reaching stable maintenance doses around weeks 12 to 16 of triple agonist therapy
If that sounds familiar, youre not alone
For your clinic, this impacts: Your service menu Treatment descriptions Consent forms Marketing materials If you say a treatment is "FDA-approved" when it isn't, or hint at benefits the data doesn't back, you risk regulatory trouble
The conversation also touches on the topic of pinealon, a peptide that can affect sleep patterns, with one individual reporting that taking it before sleep reduces deep slow-wave sleep and increases REM sleep, which may not be a desirable outcome 10m30s
Traceable compound numbers
BPC-157: 0.5 mg daily, either as single dose or split 0.25 mg twice daily TB-500: 2-2.5 mg twice weekly (Monday/Thursday) totaling 4-5 mg per week Duration: 4-6 weeks loading phase, then 2-4 weeks maintenance Important: Use separate vials and syringes for each peptide